| |
 |
|
| Science Forum Index » Medicine Forum » The global H1N1 Influenza vaccine market is estimated... |
|
Page 1 of 1 |
|
| Author |
Message |
| john... |
 Posted: Mon Nov 02, 2009 1:56 pm |
|
|
|
Guest
|
"The global H1N1 Influenza vaccine market is estimated to be of 676 million
in 2009 with first lot of doses being commercialized on 30th September'
2009. The market will see a high CAGR for the next two years i.e. the market
is expected to be at $7.03 billion in 2011 with a CAGR of 222.4% from 2009
to 2011. However, the very high CAGR will settle down by 2012 to 30% for the
period of 2009 to 2012. The reason for the sudden settle down of the growth
is that it is expected that most of the world population will be immunized
by the end of 2011."
Rest Of World H1N1 (swine flu) Vaccination Market
http://blog.taragana.com/pr/rest-of-world-h1n1-swine-flu-vaccination-market-8386/ admin November 2nd, 2009 Opportunity Analysis of H1N1 (swine flu) Vaccination Market report (http://www.bharatbook.com/Market-Research-Reports/Opportunity-Analysis-of-H1N1-swine-fluVaccination-Market.html ) assess that H1N1 Influenza A (2009) isthe first pandemic influenza of 21st century affecting more than four lacpeople in more than 180 countries across the globe in 2009. The flu broke inMexico in the month of March and then affected U.S. and after that it spreadacross the globe. H1N1 (2009) influenza have a mutation of pig, bird andhumans which has made it more dangerous and fatal compared to previousoccurrence of H1N1 (1918). The pandemic outbreak of the influenza opened the gates for the drugs suchas Tamiflu in the initial phase for the curing of the disease but thefollowing phase will see a shift from curing to prevention. Thus, arise therequirement for the vaccine for the treatment of H1N1. H1N1 vaccine marketis the forecast for the upcoming vaccines for the prevention of the diseaseamong the unaffected population. The vaccines market is classified for theintramuscular vaccines and intranasa
l vaccines. Intramuscular will cater80-85% of market revenues and the remaining will be tapped by the intranasalvaccines. The initial lot of vaccines will be of egg based and cell basedmanufacturing. The market forecast is from late 2009 as the first lot ofdoses are expected to be rolled out in the first week of October 2009. The first movers of the in the vaccines market are Glaxo Smith Kline (GSK),Novartis, CSL, Medimmune, Baxter, Sinovec and Sanofi Pastuer. Medimmune isthe only producer of the intranasal vaccine whereas other companies areexpected to come out with intramuscular vaccines. The companies have gotapprovals for their first lots from the governments of the various countriessuch as U.S., U.K., France, China, Denmark and Australia. The involvement ofgovernment bodies, increased awareness about prevention and pandemicsituation of the influenza is driving the market for the vaccines. Due tointensive ongoing research and technology introduction, the market playersare compelled to understand the market dynamics, innovations, pricing,products, marketing and regulatory framework of the market. The global H1N1 Influenza vaccine market is estimated to be of 676 millionin 2009
with first lot of doses being commercialized on 30th September'2009. The market will see a high CAGR for the next two years i.e. the marketis expected to be at $7.03 billion in 2011 with a CAGR of 222.4% from 2009to 2011. However, the very high CAGR will settle down by 2012 to 30% for theperiod of 2009 to 2012. The reason for the sudden settle down of the growthis that it is expected that most of the world population will be immunizedby the end of 2011. Market estimates and forecast * This report will enable strategic understanding and opportunities in theH1N1 2009 influenza vaccines market. The report covers the following marketsegments. * Vaccines Markets: Intramuscular Vaccines and Intranasal vaccines. * Geography Markets: North America, Europe, Asia-Pacific and ROW Each section of the report offers market data with respect to segments andgeography. It also provides market trends with respect to drivers,restraints and opportunities. The report contains strategic section withrespect to competitive landscape and market overview. The report willencompass around 15 company profiles. To know more and to buy a copy of your report feel free to visit :http://www.bharatbook.com/Market-R
esearch-Reports/Opportunity-Analysis-of-H1N1-swine-fluVaccination-Market.html Or Contact us at : Bharat Book Bureau Tel: +91 22 27578668 Fax: +91 22 27579131 Email: info at (no spam) bharatbook.com Website: www.bharatbook.com Blog: http://bharatbookresearch.blogspot.com Follow us on twitter: http://twitter.com/3bbharatbook |
|
|
| Back to top |
|
|
|
|
|
All times are GMT - 5 Hours
The time now is Mon Nov 23, 2009 5:53 am
|
|